Read Study Semaglutide and First-Time Diagnosis of Alzheimer's Disease Semaglutide is associated with a reduced risk of developing Alzheimer's disease in patients with type 2 diabetes and may have neuroprotective effects
And the whole time, you have no idea whether your medication levels are climbing, plateauing, or bouncing around like a ping pong ball between doses
Many of these new prescriptions were aimed at curbing Type 2 diabetes or as a means of losing weight, or both
Wegovy: Average weight loss in clinical trials: 14%15% Some people lost 20% or even a bit more Takes about a year to see peak results Zepbound: Early studies show 10%15% Some users report fewer stomach issues, so they stay on it more consistently Less long-term data since its newer Realistically, your results depend on your lifestyle, age, metabolism, and if you actually stay on the medication
How important is the purity of the peptides in this comparison
Jonathan Gelber, MD and LA Ortho and Wellness are able to provide peptide therapy in Toluca Lake, North Hollywood, Burbank, and Studio City